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1. Introduction 
In 1856, Rudolf Virchow published “Cellular pathology” based on macroscopic and 
microscopic observation of diseases, and described a triad of factors on thrombosis. The 
three components were vascular change, blood flow alteration, and abnormalities of blood 
constituents. Although Virchow originally referred to venous thrombosis, the theory can 
also be applied to arterial thrombosis, and it is considered that atherothrombus formation is 
regulated by the thrombogenicity of exposed plaque contents, local hemorheology, and 
blood factors. Thrombus formation on a disrupted atherosclerotic plaque is a critical event 
that leads to atherothrombosis. However, it does not always result in complete thrombotic 
occlusion with subsequent acute symptomatic events (Sato et al., 2009). Therefore, thrombus 
growth is also critical to the onset of clinical events. In spite of intensive investigation on the 
mechanisms of thrombus formation, little is known about the mechanisms involved in 
thrombogenesis or thrombus growth after plaque disruption, because thrombus is assessed 
with chemical or physical injury of “normal” arteries in most animal models of thrombosis.  
Vascular change is an essential factor of atherothrombosis. Atherothrombosis is initiated by 
disruption of atherosclerotic plaque. The plaque disruption is morphologically 
characterized, however, the triggers of plaque disruption have not been completely 
understood. Tissue factor (TF) is an initiator of the coagulation cascade, is normally 
expressed in adventitia and variably in the media of normal artery (Drake et al., 1989). 
Because the atherosclerotic lesion expresses active TF, it is considered that TF in 
atherosclerotic lesion is a major determinant of vascular wall thrombogenicity (Owens & 
Mackman, 2010). Therefore, atherosclerotic lesions with TF expression are indispensable for 
studying atherothrombosis. To examine thrombus formation on TF-expressing 
atherosclerotic lesions, we established a rabbit model of atherothrombosis (Yamashita et al., 
2003, 2009). This allowed us to investigate the “Virchow’s triad” on atherothrombosis.  
Blood flow is a key modulator of the development of atherosclerosis and thrombus 
formation. The areas of disturbed flow or low shear stress are susceptible for atherogenesis, 
whereas areas under steady flow and physiologically high shear stress are resistant to 
atherogenesis (Malek et al., 1999). The transcription of thrombogenic or anti-thrombogenic 
genes is also regulated by shear stress (Cunningham & Gotlieb, 2005). The blood flow can be 
altered by vascular stenosis, acute luminal change after plaque disruption, and micovascular 
constriction induced by distal embolism (Topol & Yadav, 2003). The blood flow alteration 
after plaque disruption may affect thrombus formation.  
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Blood circulates in the vessel as a liquid. This property suddenly changes after plaque 
disruption. The exposure of matrix proteins and TF induce platelet adhesion, aggregation 
and activation of coagulation cascade, resulted in platelet-fibrin thrombus formation. 
Clinical studies revealed increased platelet reactivity, coagulation factors, and reduced 
fibrinolytic activity in patients with atherothrombosis (Feinbloom & Bauer, 2005), and that 
risk factors for atherothrombosis can affect these blood factors (Lemkes et al., 2010, Rosito et 
al., 2004). In addition, recent evidences suggest that white blood cells can influence arterial 
thrombus formation. It seems that abnormalities on blood factors affect thrombus growth 
rather than initiation of thrombus formation.  
This article focuses on pathology and pathophysiology of coronary atherothrombosis. 
Because mechanisms of atherothrombus formation are highly complicated, we separately 
discuss the “Virchow’s triad” on atherothrombogenesis and thrombus growth.  
2. Pathology of atherothrombosis 
Traditionally, it is considered that arterial thrombi are mainly composed of aggregated 
platelets because of rapid blood flow condition, and the development of platelet-rich 
thrombi has been regarded as a cause of atherothrombosis. However, recent evidences 
indicate that atherothrombi are composed of aggregated platelets and fibrin, along 
erythrocytes and white blood cells, and constitutively immunopositive for GPIIb/IIIa (a 
platelet integrin), fibrin, glycophorin A (a membrane protein expressed on erythrocytes), 
von Willbrand factor (VWF, a blood adhesion molecule). And neutrophils are major white 
blood cells in coronary atherothrombus (Nishihira et al., 2010, Yamashita et al., 2006a). 
GPIIb/IIIa colocalized with VWF. TF was closely associated with fibrin (Yamashita et al., 
2006a). The findings suggest that VWF and/or TF contribute thrombus growth and 
obstructive thrombus formation on atherosclerotic lesions, and that the enhanced platelet 
aggregation and fibrin formation indicate excess thrombin generation mediated by TF.    
Overexpression of TF and its procoagulant activity have been found in human 
atherosclerotic plaque, and TF-expressing cells are identified as macrophages and smooth 
muscle cells (SMC) in the intima (Wilcox et al., 1989). The TF activity is more prominent in 
fatty streaks and atheromatous plaque than in the diffuse intimal thickening in aorta 
(Hatakeyama et al., 1997). Thus, atherosclerotic plaque has a potential to initiate coagulation 
cascade after plaque disruption, and TF in the plaque is thought to play an important role in 
thrombus formation after plaque disruption. Interestingly, TF pathway inhibitor (TFPI), a 
major down regulator of TF-factor VIIa (FVIIa) complex, is also upregulated in 
atherosclerotic lesions (Crawley et al., 2000). In addition to endothelial cells, macrophages, 
medial and intimal SMCs express TFPI. These evidence suggest that imbalance between TF 
and TFPI contribute to vascular wall thrombogenicity.    
Two major patterns of plaque disruption are plaque rupture and plaque erosion (Figure 1). 
Plaque rupture is caused by fibrous cap disruption, allowing blood to come in contact with 
the thrombogenic necrotized core, resulting in thrombus formation. Ruptured plaque is 
characterized by disruption of thin fibrous caps, usually less than 65 μm in thickness, rich in 
macrophages and lymphocytes, and poor in SMCs (Virmani et al., 2000). Thus, the thinning 
of the fibrous cap is though to be a state vulnerable to rupture, the so-called thin-cap 
fibroatheroma (Kolodgie et al., 2001). However, the thin-cap fibroatheroma is not taken into 
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account in the current American Heart Association classification of atherosclerosis (Stary et 
al., 1995). Plaque erosion is characterized by a denuded plaque surface and thrombus 
formation, and defined by the lack of surface disruption of the fibrous cap. Compared with 
plaque rupture, patients with plaque erosion are younger, no male predominance. 
Angiographycally, there is less narrowing and irregularity of the luminal surface in erosion. 
The morphologic characteristics include an abundance of SMCs and proteoglycan matrix, 
expecially versican and hyaluronan, and disruption of surface endothelium. Necrotic core is 
often absent. Plaque erosion contains relatively few macrophages and T cells compared with 
plaque rupture (Virmani et al., 2000). Thrombotic occlusion is less common with plaque 
erosion than plaque rupture, whereas microembolization in distal small vessels is more 
common with plaque erosion than plaque rupture (Schwartz et al., 2009). The proportions of 
fibrin and platelets differ in coronary thrombi on ruptured and eroded plaques. Thrombi on 
ruptured plaque are fibrin-rich, but those on eroded plaque are platelet-rich. TF and C 
reactive protein (CRP) are abundantly present in ruptured plaque, compared with eroded 
plaques (Sato et al., 2005). These distinct morphologic features suggest the different 
mechanisms in plaque rupture and erosion. 
500μm 
500μm 
100μm 
100μm 
100μm 
100μm 
GPIIb/IIIa Fibrin
rupture
erosion
HE
 
Fig. 1. Human coronary plaque rupture and erosion in patients with acute myocardial 
infarction.  
Large necrotic core and disrupted thin fibrous cap is accompanied by thrombus formation 
in ruptured plaque. Eroded plaque has superficial injury of SMC-rich atherosclerotic lesion 
with thrombus formation. Both thrombi comprise platelets and fibrin. HE, Hematoxylin 
eosin stain (from Sato et al. 2005, with permission). 
3. Pathology of asymptomatic atherothrombus 
On the other hands, the disruption of atherosclerotic plaque does not always result in 
complete thrombotic occlusion with subsequent acute symptomatic events. The clinical 
studies using angioscopy have revealed that multiple plaque rupture is a frequent 
complication in patients with coronary atherothrombosis (Okada et al., 2011). Healed stages 
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of plaque disruption are also occasionally observed in autopsy cases with or without 
coronary atherothrombosis (Burke et al., 2001). To evaluate the incidence and morphological 
characteristics of thrombi and plaque disruption in patients with non-cardiac death, Sato et 
al. (2009) examined 102 hearts from non-cardiac death autopsy cases and 19 from those who 
died of acute myocardical infarction (AMI). They found coronary thrombi in 16% of cases 
with non-cardiac death, and most of them developed on plaque erosion, and the thrombi 
were too small to affect coronary lumen (Figure 2, Table 1). The disrupted plaques in non-
cardiac death case had smaller lipid areas, thicker fibrous caps, and more modest luminal 
narrowing than those in cases with AMI. A few autopsy studies have examined the 
incidence of coronary thrombus in non-cardiac death. Davies et al. (1989) and Arbustini et 
al. (1993) found 3 (4%) mural thrombi in 69, and 10 (7%) thrombi in 132 autopsy cases with 
non-cardiac death. The all coronary thrombi from non-cardiac death were associated with 
plaque erosion (Arbustini et al., 1993). Although the precise mechanisms of plaque erosion 
remain unknown, it is possible that the superficial erosive injury is a common mechanism of 
coronary thrombus formation. The results suggest that plaque disruption does not always 
result in complete thrombotic occlusion with subsequent acute symptomatic events, that 
thrombus growth is critical step for the onset of clinical events, and that at least the regional 
factors influence the size of coronary thrombus after plaque disruption.  
 
Fig. 2. Human coronary plaque erosion in patient with non-cardiac death.  
 
Non-cardiac death
(n=102) 
Acute myocardial infarction 
(n=19) 
P value 
Fresh thrombus 10 (10%) 14 (74%) <0.001 
erosion 7 (7%) 4 (21%) 0.07 
rupture 3 (3%) 10 (53%) <0.001 
Old thrombus 6 (6%) 5 (26%) <0.05 
(From Sato et al. 2009, with permission) 
Table 1. Incidence of thrombosis in non-cardiac death and acute myocardial infarction. 
www.intechopen.com
 
Pathology and Pathophysiology of Atherothrombosis: Virchow’s Triad Revisited 
 
5 
The atherosclerotic lesion shows superficial erosive injury with mural thrombus (arrows). 
The thrombus is too small to obstruct coronary lumen and induce symptomatic event 
(hematoxyline eosin stain, from Sato et al. 2009, with permission). 
4. Pathophysiology of atherothrombosis 
4.1 Triggers on plaque disruption 
As described above, atherothrombosis is initiated by plaque rupture or plaque erosion. The 
plaque disruption is probably affected by vascular wall change and local blood flow. Our 
recent study revealed that disturbed blood flow could trigger plaque erosion in rabbit 
femoral artery with SMC-rich plaque. We separately discuss possible factors that affect 
plaque rupture or plaque erosion in atherosclerotic vessels. 
4.1.1 Vascular change in plaque rupture 
The thinning and disruption of fibrous cap by metalloproteases together with local rheological 
forces and emotional status is likely to be involved in plaque rupture. Accumulating evidence 
supports a key role for inflammation in the pathogenesis of plaque rupture. The inflammatory 
cells that appear quite numerous in rupture-prone atherosclerotic plaques can produce 
enzymes degrading the extracellular matrix of the fibrous cap. Macrophages in human 
atheroma overexpress interstitial collagenases and gelatinases, and elastolytic enzymes. 
Activated T lymphocytes and macrophages can secrete interferon Ǆ (INF-Ǆ), which inhibits 
collagen synthesis and induces apoptotic death of SMC (Shah, 2003). Moreover, INF-Ǆ can 
induce interleukine (IL)-18, an accelerator of inflammation. IL-18 is colocalized with INF-Ǆ in 
macrophage located at shoulder region, but not at necrotic core, and is associated with 
coronary thrombus formation in patients with ischemic heart disease (Nishihira et al., 2007). 
IL-10, an important anti-inflammatory cytokine, also is upregulated in macrophage in 
atherosclerotic lesion from patients with unstable angina compared with stable angina 
(Nishihira et al., 2006b). Heterogeneity of macrophages in atherosclerotic plaque could explain 
the paradoxical findings (Waldo et al., 2008). These evidences indicate that the imbalance of 
inflammatory pathway appear to participate in the destabilization of the plaque that triggers 
thrombosis in fibrous cap rupture.  
Other possible trigger of plaque rupture is intraplaque hemorrhage. The frequency of 
previous hemorrhages is greater in coronary atherosclerotic lesions with late necrosis and 
thin fibrous cap than those lesions with early necrosis or intimal thickening (Kolodgie et al., 
2003). Plaque hemorrhage is present in majority (>75%) of acute ruptures, and in 40% of 
fibrous cap and thin-fibrous cap atheromas. In addition, intraplaque hemorrhage is more 
frequently seen in patients with AMI compared to patients with healed myocardial 
infarction or non-cardiac death (Virmani et al., 2003). In coronary culprit lesions obtained by 
directional coronary atherectomy, intraplaque hemorrhage and iron deposition were more 
prominent in patients with unstable angina pectoris than with stable angina pectoris. The 
iron deposition correlated with oxidized low density lipoprotein and thioredoxin, an anti-
oxidant protein, and was also associated with thrombus formation (Nishihira et al., 2008b). 
The pathological findings imply a possible relationship among intraplaque hemorrhage, 
oxidative stress, and plaque instability. However, the direct evidence that links intraplaque 
hemorrhage to plaque instability is still lacking. 
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4.1.2 Blood flow-induced mechanical stress on plaque rupture 
Blood flow-induced mechanical stress is an essential factor of development of 
atherosclerosis and atherothrombosis. The low shear stress and oscillatory shear stress are 
both important stimuli for induction of atherosclerosis. Using a perivascular shear stress 
modifier in mice, Cheng et al. (2006) revealed that low shear stress induces larger lesions 
with vulnerable plaque phenotype (more lipids, more proteolytic enzymes, less SMCs, and 
less collagen) whereas vortices with oscillatory shear stress induce stable lesions. Chatzizisis 
et al. (2011) reported development of thin fibrous cap atheroma in coronary artery with low 
shear stress in pigs. In addition, the shear stress-induced changes in atherosclerotic plaque 
composition are modulated by chemokines. Inhibition of fractalkine, which is exclusively 
expressed in the low shear stress-induced atherosclerotic plaque, was reduced lipid and 
macrophage accumulation in the brachiocephalic arteries in mice (Cheng et al., 2007). 
Therefore, lower shear stress can induce atherosclerotic lesion prone to plaque rupture. 
Although it is well recognized that a mechanical stress triggers the disruption of fibrous cap, 
it remains unclear which factor is mainly responsible for the disruption of the thin fibrous 
cap. A variety of mechanical factors have been postulated to play a role in plaque rupture, 
including hemodynamic shear stress, turbulent pressure fluctuation (Loree et al., 1991), 
sudden increases in intraluminal pressure (Muller et al., 1989), and tensile stress 
concentration within the wall of the lesion. To investigate the relationship between shear 
stress distribution and coronary plaque rupture, Fukumoto et al. (2008) analyzed 3-
dimmensional intravascular ultrasound images in patients with acute coronary thrombosis 
by a program for calculating the fluid dynamics. The ruptured sites were located in the 
proximal or top portion of the plaques, and the localized high shear stress is frequently 
correlated with the rupture sites. This finding is inconsistent with role of low shear stress on 
atherogenesis. It is possible that the process of initiating plaque rupture is quite different 
form that of atherogenesis. On the other hand, an excessive concentration of tensile stress 
within the plaque may be one of the triggers of plaque rupture. When the tensile stress 
becomes greater than the fragility of the fibrous cap, a plaque disruption may be initiated. 
The tensile stress is increased by development of a lipid core, thinning of the fibrous cap 
(Loree et al., 1992). Cheng et al. (1993) analyzed the distribution of circumferential stress in 
human coronary arteries. The maximum circumferential stress in ruptured plaques was 
significantly higher than that in stable plaques, although plaque rupture does not always 
occur at the region of highest stress. These results suggest that a mechanical factor that 
triggers plaque rupture differ in each case and lesion. 
4.1.3 Disturbed blood flow on plaque erosion 
Although it has been postulated that erosions result from coronary vasospasm of SMC-rich 
plaque, the mechanisms of plaque erosion are poorly understood. Approximately 80% 
thrombi of plaque erosion are nonocclusive in spite of sudden coronary death (Virmani et 
al., 2000). Platelet rich emboli are found in 74% of patients dying suddenly with plaque 
erosion compared with plaque rupture (40%). Because activated platelets release 
vasoconstrictive agents, such as 5-hydroxytriptamine (5-HT, serotonin) and thromboxane 
A2, these emboli might increase peripheral resistance leading to alteration of coronary blood 
flow. 5-HT can induce vasoconstriction and reduce coronary blood flow in human 
atherosclerotic vessels but not in normal arteries (Golino et al., 1991).  
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Experimental aortic stenosis can induce acute endothelial change or damage of the normal 
aorta (Fry, 1968). Therefore, hemodynamic force, particularly disturbed blood flow induced 
by stenosis or vasoconstriction, could be a crucial factor in generating surface vascular 
damage and thrombosis. To address the relation between disturbed blood flow and plaque 
erosion, we investigated the pathological change after acute luminal narrowing in SMC-rich 
plaque in rabbit. The SMC-rich plaque was induced by a balloon injury of rabbit femoral 
artery, and expressed TF as human atherosclerotic plaques. Actually, the disturbed blood by 
acute vascular narrowing induced superficial erosive injury to the SMC-rich plaque at post 
stenotic regions in rabbit femoral arteries. Figure 3 shows microscopic images of the 
longitudinal section of the neointima at the post- stenotic region 15 min after vascular 
narrowing. The endothelial cells and SMCs at this region were broadly detached with time, 
and associated with platelet adhesion to the sub-endothelium. Apoptosis of endothelial cells  
 
 
 
Fig. 3. Representative images of superficial erosive injury of SMC-rich plaque and thrombus 
formation at the post-stenotic region.  
SMC-rich plaque 15 min after vascular narrowing shows endothelial detachement (small 
arrows) accompanies platelet adhesion (arrow heads) at 1mm form vascular narrowing (A, 
hematoxyline eosin stain). Detachment of endothelial cells and exposure of subendothelial 
matrix is accompanied by platelet aggregation on the left side, and residual endothelial cell 
layer is present on right side (inset, high magnification of aggregated platelets) (B. scanning 
electron microscopy). Immunohistochemistry for VWF (C, a marker of endothelium) or 
smooth muscle actin (D, a marker of SMC) confirm detachment of endothelial cells and 
SMCs at post stenotic region (from Sumi et al. 2010, with permission).   
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and superficial SMCs was also observed at the post- stenotic region within 15 minutes (Sumi 
et al., 2010). The vascular narrowing induced large mural thrombi which composed of 
platelets and fibrin, as human plaque erosion. Thus, disturbed blood flow can induce 
superficial erosive injury to SMC-rich plaque and thrombus formation at post stenotic 
region. Computational fluid simulation analysis indicated that oscillatory shear stress 
contributes to the development of the erosive damage to the plaque (Sumi et al., 2010). 
Although direct clinical evidence has not yet supported the notion that coronary artery 
vasospasm plays a role in plaque erosion, the superficial erosive injury of SMC-rich plaque 
by disturbed blood flow is similar to those of human plaque erosion (Sato et al., 2005). And, 
platelet and blood coagulation in coronary circulation are activated after vasospastic angina 
(Miyamoto et al. 2001, Oshima et al., 1990). Therefore, these evidence suggest that an acute-
onset disturbed blood flow due to vasoconstriction could trigger plaque erosion. 
Hemodynamic factors could play an important role in development of plaque erosion.  
4.2 Virchow’s triads on thrombus growth 
As described above, plaque disruption does not always result in complete thrombotic 
occlusion. Thrombus growth is considered critical to the onset of clinical events. Although 
thrombus formation is regulated by the vascular wall thrombogenicity, local blood flow, 
and blood contents, their contribution to thrombus growth has not been clearly defined. We 
separately discuss three factors that affect thrombus growth in atherosclerotic vessels. 
4.2.1 Vascular factors on thrombus growth 
Most fundamental difference between normal artery and atherosclerotic artery is presence 
of abundant active TF in atherosclerotic lesions (Hatakeyama et al., 1997, Wilcox et al., 1989). 
It seems that vascular wall TF contribute to thrombus size/propagation on atherosclerotic 
lesions. However, recent studies indicate that a small amount of TF is detectable in the blood 
and is capable of supporting clot formation in vitro. Plasma TF levels are elevated in 
patients with unstable angina and AMI and correlate with adverse outcomes (Mackman, 
2004). Therefore, it is still controversial whether vascular wall and/or blood-derived TF 
support thrombus propagation. Hematopoietic cell-derived, TF-positive microparticles 
contributed to laser injury-induced thrombosis in the microvasculature of mouse cremaster 
muscle (Chou et al. 2004). In contrast, vascular smooth muscle-derived TF contributed to 
FeCl3 induced thrombosis in mouse carotid artery (Wang et al., 2009). We investigated 
whether plaque and/or blood TF contribute to thrombus formation in rabbit femoral artery 
with or without atherosclerotic lesions. The atherosclerotic lesions in rabbit femoral arteries 
were induced by a 0.5% cholesterol diet and balloon injury, and showed TF expression and 
increased procoagulant activity compared with normal femoral arteries (Figure 4). Balloon 
injury of the atherosclerotic plaque induced thrombin-dependent large platelet-fibrin 
thrombi. In contrast, balloon injury of normal femoral artery induced thrombin-independent 
small platelet thrombi (Figure 5). Moreover, whole blood coagulation in the rabbits was not 
affected by blood TF inhibition with a TF antibody even in hyperlipidemic condition 
(Yamashita et al., 2009). Therefore, at least, atherosclerotic plaque-derived TF might 
contribute to activation of intravascular coagulation cascade and thrombus 
size/propagation on atherosclerotic lesions.  
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Fig. 4. Histological images of rabbit femoral arteries. 
Representative immunohistochemical microphotographs of normal (A) and balloon-injured 
femoral artery at 3 weeks after injury under 0.5% cholesterol diet (B). Atherosclerotic lesion 
composed of SMCs and macrophages develops in injured artery. TF expression is present in 
the lesion and adventitia of both arteries. HE/VB, hematoxyline eosin/Victoria blue stain 
(From Yamashita et al. 2009, with permission). 
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Fig. 5. Immunofluorescence images of thrombus on rabbit femoral artery. 
Representative immunofluorescent microphotographs of thrombi 15 minutes after balloon 
injury of normal femoral artery and of atherosclerotic plaque under 0.5% cholesterol diet. 
Rows show differential interference contrast images, images stained with fluorescein 
isothiocyanate-labeled GPIIb/IIIa (green), Cy3-labeled fibrin (red), and merged 
immunofluorescent images. Areas with colocalized factors are stained yellow. The thrombi 
on normal intima is composed of small aggregated platelet (A), while the thrombi on 
atherosclerotic plaque is large, and composed of platelet and fibrin (B). I, intima; M, media; 
IEL, internal elastic lamina. (From Yamashita et al. 2009, with permission). 
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Several factors can influence TF expression in plaques and atherothrombus formation after 
plaque disruption. CRP is an inflammatory acute-phase reactant that has emerged as a 
powerful predictor of cardiovascular disease (Ridker, 2007). CRP is localized in 
atherosclerotic plaques and is more in thrombotic plaques than non-thrombotic ones 
(Ishikawa et al., 2003, Sun et al., 2005). The findings imply that CRP is implicated in 
atherothrombogenesis. To address this issue, CRP-transgenic rabbits were generated, 
because as human CRP, CRP in rabbits but not in mice works as an acute-phase reactant 
during inflammation (Koike et al., 2009). In the rabbits, CRP was overexpressed in livers and 
circulated in blood and deposited in the both SMC-rich and macrophage-rich atherosclerotic 
lesions. The thrombus size on SMC-rich plaque or macrophage-rich plaque after balloon 
injury was significantly increased in CRP-transgenic rabbits as compared with wild non-
transgenic rabbits (Figure 6). TF expression and its acivity in the plaques were significantly 
increased in CRP-transgenic rabbits. The degree of CRP deposition correlated with TF 
expression in plaques and thrombus size on injured plaques (Matsuda et al., 2011). On the  
 
100μm 
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GP IIb/IIIa 
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100μm 
Non-transgenic Rb CRP-transgenic Rb
 
 
Fig. 6. Thrombus formation on SMC-rich plaque in CRP-transgenic or non-transgenic rabbit 
femoral artery.  
The images show thrombus formation on SMC-rich plaque (arrows) 15 min after balloon 
injury of rabbit femoral arteries. The thrombus size is increased in CRP-transgenic rabbits as 
compared with non-transgenic rabbit. Immunopositive areas for GPIIb/IIIa and fibrin also 
increase in CRP-transgenic rabbit (from Matsuda et al. 2011, with permission).  
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other hand, the CRP overexpression did not enhance atherosclerosis induced by 
hyperchoresterol diets (Koike et al., 2009). CRP localized in atherosclerotic plaques might 
enhance vascular wall thrombogenicity and thrombus formation after plaque disruption 
rather than atherogenesis.      
4.2.2 Altered blood flow on thrombus growth 
Blood flow is a key modulator of thrombus growth. Clinical studies revealed an alteration of 
coronary blood flow in patients with ischemic heart diseases. Marzilli et al. (2000) reported 
an approximate 80% reduction in coronary blood flow during ischemia in patients with 
unstable angina. An autopsy study reported that intramyocardial microemboli were 
frequently present in sudden coronary death patients (Schwartz et al. 2009). Distal 
microvascular embolism and/or vasoconstriction could affect blood flow alteration and 
thrombus formation and growth at the culprit lesions (Erbel & Heusch, 2000). To assess the 
issue, we examined the effects of the blood flow reduction to thrombus formation in our 
animal model. Blood flow reduction (>75%) promoted the growth of thrombus, a mixture of 
platelets and fibrin, on atherosclerotic lesion, which grew to occlusive one. The flow 
reduction also induced thrombus formation on normal arteries, but the thrombi were very 
small and composed only of platelets (Yamashita et al. 2004). Therefore, blood flow 
reduction associated with increased vascular wall thrombogenecity is considered to 
contribute thrombus growth. We also demonstrated an important role of 5-HT2A receptor on 
platelets and SMCs in this process via platelet aggregation and thrombogenic 
vasoconstriction (Nishihira et al., 2006a, 2008a). 
In addition to distal vascular resistance, disturbed blood flow by acute vascular narrowing 
promotes thrombus growth at post stenotic regions. As described above, vascular narrowing 
of rabbit femoral artery induced superficial erosive injury to SMC-rich plaque at post 
stenotic regions. The thrombi consisted of a mixture of aggregated platelets and a 
considerable amount of fibrin. The whole blood hemostatic parameters in the rabbits was 
not changed after vascular narrowing or anti-rabbit TF antibody treatment, which evidence 
indicates that TF derived from eroded plaque rather than circulating TF plays an important 
role in fibrin generation and thrombus growth (Sumi et al. 2010).  
The rheological effect on thrombus growth may be partly explained by a shear gradient-
dependent platelet aggregation mechanism. Using in vitro and in vivo stenotic microvessels 
and imaging systems, Nesbitt et al. (2009) revealed a shear gradient-dependent platelet 
aggregation process which is preceded by soluble agonist-dependent aggregation. Shear 
microgradient at post stenosis region or down stream face of thrombi induced stable 
platelets aggregates, and the shear microgradients directly influenced the platelet 
aggregation size. This process required ligand binding to integrin ǂIIbǃ3, transient Ca2+ flux, 
but did not required global platelet shape change or soluble agonists. The findings suggest 
that platelets principally use a biomechanical platelet aggregation mechanism in early phase 
of platelet adhesion and aggregation. Vessel and/or thrombus geometry itself may promote 
thrombus formation.  
4.2.3 Blood factors on thrombus growth 
As described above, platelet is a major cellular component in coronary thrombus, and 
platelets play an important role in growing phase of thrombus formation, as well as initial 
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phase of thrombus formation. Adhesion molecules and its receptors on platelets are 
essential for thrombus formation, because these molecules support platelet tethering, firm 
adhesion, aggregation and platelet recruitment to thrombus surface. VWF is a large, 
multimeric, plasma protein that undergoes a conformational change when bound to matrix 
under permit its binding to GPIbǂ. Recent studies in vitro and in vivo showed that platelet 
recruitment on thrombus surface was primary mediated by VWF and GPIbǂ on flowing 
platelets (Bergmeier et al. 2006, Kulkuni et al. 2000). We demonstrated that a large amount 
of VWF was localized in coronary thrombi in patients with AMI (Nishihira et al., 2010, 
Yamashita et al., 2006a), and that monoclonal antibody against VWF A1 domain, which 
interacts platelet GPIbǂ, significantly suppressed formation of platelet-fibrin thrombi and 
completely inhibited occlusive thrombus formation in rabbit atherosclerotic lesions 
(Yamashita et al., 2003, 2004). These findings indicated a crucial role of VWF in thrombus 
growth via platelet recruitment. The multimer size of VWF can affect thrombus size and is 
regulated by a plasma protease, a disintegrin and metalloprotease with a thrombospondin 
type 1 motif 13 (ADAMTS-13). A deficiency of ADAMTS-13 activity causes an increased 
level of circulating ultralarge VWF multimers, and correlates with the onset of the general 
thrombotic disease, thrombotic thrombocytopenic purpura (TTP). A clinical evidence 
suggested dysregulation of VWF multimer size in AMI patient. The ratio of 
VWF/ADAMTS-13 antigen was higher in patients with AMI than in those with stable 
angina pectris, and there was a inverse correlation between plasma VWF antigen and 
ADAMTS-13 activity in AMI patients (Kaikita et al. 2006). The ADAMTS-13 closely localized 
with VWF in fresh coronary thrombi from AMI patients (Moriguchi-Goto et al., 2009). A 
reducing ADAMTS-13 activity by monoclonal antibody against distintegrin-like domain 
enhanced platelet thrombus growth on immobilized type I collagen at a high shear rate 
(1500S-1) and platelet-fibrin thrombus formation on injured atherosclerotic lesion of rabbit 
femoral arteries (Moriguchi-Goto et al., 2009). The study also showed cleavage of large sized 
VWF multimer during platelet thrombus formation under a high shear rate. The VWF-
cleaving site by ADAMTS-13 localized on the surface of platelet thrombus, and the 
ADAMTS-13 activity was shear dependent manner (Shida et al. 2008). Thus, ADAMTS-13 
may work at the site of ongoing thrombus generation and limit thrombus growth.   
The recent studies in vitro showed various blood cells, not only monocytes but also 
neutrophils, eosinophils, and even if platelets, can synthesize TF. Although there is much on 
debate on the TF expression in blood cells, it is likely that monocytes are the only blood cells 
that synthesize and express TF (Østerud, 2010). A related topic is contribution of 
microparticles (MPs) to thrombus formation. MPs are small fragments of membrane-bound 
cytoplasm that are shed from the surface of an activated or apoptotic cells (Blann et al. 2009). 
The procoagulant activity of MPs is increased with the exposure of phosphatidylserine and 
the presence of TF. In fact, MPs have significantly elevated in acute coronary syndrome and 
ischemic strokes (Geiser et al. 1998, Singh et al. 1995). However, it is still unclear whether the 
elevated levels of MPs are a cause or consequence of atherothrombosis. Moreover, our 
animal studies did not support the role of blood-derived TF in atherothrombus formation as 
described above. Future studies are required to clarify contribution of blood derived TF 
and/or MPs to thrombus propagation on atherosclerotic lesions.    
Among the white blood cells, neutrophils are mostly found in coronary thrombus in 
patients with AMI, and CD34 positive leukocytes are also found in the thrombus (Nishihira 
et al., 2010). Recent evidences revealed neutrophils and endothelial progenitor cells 
influence thrombus growth. Neutrophils can positively or negatively affect thrombus 
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formation by degradation of coagulation or fibrinolysis factors and promoting platelet 
function (Kornecki et al., 1988, Moir et al., 2002). Inhibition of interaction between p-selectin 
and p-selectin glycoprotein ligand 1 reduced fibrin formation in vivo (Palabrica et al., 1992). 
These adhesion molecules have been implicated in recruitment of leukocytes and leukocyte 
MPs to thrombi (Vandendries et al., 2004). To reveal the neutrophil-mediated procoagulant 
mechanisms, Massberg et al. (2010) investigated thrombus formation using neutrophil 
elastase and cathepsin G deficient mice. Proteolysis of TFPI by these proteases enhanced 
fibrin and thrombus formation after FeCl3-induced vessel injury. In addition, activated 
platelets by collagen accelerated nucleosome externalization by neutrophils. The neutrophil-
derived externalized nucleosomes can form neutrophil extracellular traps that provide a 
scaffold for platelets and red blood cells and histone 3/4 can induce platelet aggregation 
(Fuchs et al., 2010). On the other hands, neutrophil elastase has fibriolytic potential, and 
there is significant correlation between neutrophil elastase-digested fibrin and leukocyte 
content in human atherothrombi (Rábai et al., 2010). Zeng et al. (2002) investigated 
contribution of polymorphonuclear leukocytes (PMNs) to fibrinolysis in vivo using 
plasminogen deficient mice. The PMNs accumulated within the thrombi by 6 hours after 
FeCl3-induced vessel injury and peaked at 24 hours. There were no significant differences 
between the PMNs from plasminogen deficient mice and wild type mice within the 6 hour 
after thrombus formation, whereas there was significant greater retention of PMNs within 
the thrombus over 24 hours after thrombus formation. PMNs from both mice showed 
fibrinolytic activity, but the degradation products were a distinct pattern. Therefore, it is 
possible that neutrophils works as positive or negative regulator of early or late phase of 
thrombus formation, respectively.  
Endothelial progenitor cells (EPC) contributes to angiogenesis and wound healing (Asahara 
et al., 1997), and the number of EPCs in blood is associated with cardiovascular risk (Hill et 
al., 2003). The mechanisms that regulate mobilization, migration, and differentiation of EPCs 
and their homing to sites of vascular injury are complex and involve several mediators and 
receptors, such as P-selectin glycoprotein ligand-1, CXC chemokine, and integrins (Chavakis 
et al., 2005, Massberg et al., 2006). Interaction of thrombus contents and EPCs influences 
their mobilization and differentiation to mature endothelial cells during vascular injury (de 
Boer HC et al., 2006). Abou-Saleh et al. (2009) reported that human peripheral blood 
mononuclear cell derived EPCs bound platelets via p-selectin and inhibit platelet activation, 
aggregation, and adhesion to collagen in vitro, and that injection of these EPCs reduced 
thrombus formation after FeCl3-induced vessel injury of mouse carotid arteries.    
Other possible mechanism contributing thrombus propagation in vivo is intrinsic 
coagulation pathway. The intrinsic coagulation pathway is initiated when coagulation factor 
XII (FXII) comes into contact with negatively charged surfaces in a reaction involving the 
plasma proteins, high molecular mass kininogen and plasma kallikrein. Factor XI (FXI) is 
activated by activated FXII, thrombin, and activated XI. Feedback activation of FXI by 
thrombin promotes further thrombin generation in vitro (Gailani & Broze, 1991). FXI was 
present in platelet-fibrin thrombus induced balloon injury of atherosclerotic lesion in 
rabbits, and anti-FXI antibody reduced thrombus growth without prolonging bleeding 
(Yamashita et al., 2006b). FXI plays an important role in thrombus growth via further 
thrombin generation. On the other hand, there are conflicts of evidence that FXII supports 
arterial thrombus growth. FXII deficient mice were resistant to thrombotic occlusion after 
FeCl3 induced vessel injury of carotid arteries (Cheng Q et al., 2010). However, a clinical 
study demonstrated an inverse relationship between FXII level and risk of myocardial 
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infarction (Doggen et al., 2006). Moreover, inhibition of FXII did not change platelet 
aggregation and fibrin formation on atherosclerotic plaque surface under flow in vitro. The 
effect of FXII on coagulation became obvious only absence of TF (Reininger et al., 2010).  
5. Conclusion 
More than 150 years ago, Virchow described the mechanims of thrombus formation. It has 
still remained as a fundamental theory of thrombus formation. To date, pathological and 
experimental studies have clarified the mechanisms of atherothrombus formation. The 
thrombus formation is initiated by plaque rupture and plaque erosion. Among the 
Virchow’s triad, vascular and rheological factors are responsible for plaque rupture. 
Disruption of thin fibrous cap atheroma triggers plaque rupture. On the other hand, 
disturbed blood by acute luminal change can trigger plaque erosion to SMC-rich plaque. 
Pathological findings of human atherothrombosis suggest that thrombus growth rather than 
plaque disruption is a critical step for the onset of cardiovascular events, and that 
simultaneous activation of coagulation cascade and platelets play an important role in 
thrombus formation after plaque disruption. All three factors contribute to atherothrombus 
growth. Our rabbit model of atherothrombosis revealed that excess thrombin generation 
mediated by plaque TF contribute to large plate-fibrin thrombus formation on 
atherosclerotic lesion, and that disturbed flow condition after plaque disruption promote 
thrombus growth. Recent evidence suggests that leukocytes influence arterial thrombus 
formation as well as platelet and coagulation/fibrinolysis factors. Differences between 
hemostasis and thrombus growth may shed light on a novel anti-atherothrombogic drug 
with a wide safety margin. 
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